Conference Celebrates N.C.'s Expanding Biotech Community; Biotech 2003 Pinpoints Growth, Potential of Biotechnology in the State.Business Editors/Health/Medical Writers CED (Capacitance Electronic Disc) An earlier videodisc technology from RCA that was released in 1981 and abandoned five years later. Like phonograph records, the analog disc contained grooves that a stylus rode over. Biotech 2003 RESEARCH TRIANGLE PARK Research Triangle Park, research, business, medical, and educational complex situated in central North Carolina. It has an area of 6,900 acres (2,795 hectares) and is 8 × 2 mi (13 × 3 km) in size. Named for the triangle formed by Duke Univ. , N.C.--(BUSINESS WIRE)--May 21, 2003 The Council for Entrepreneurial Development (CED), along with the North Carolina North Carolina, state in the SE United States. It is bordered by the Atlantic Ocean (E), South Carolina and Georgia (S), Tennessee (W), and Virginia (N). Facts and Figures Area, 52,586 sq mi (136,198 sq km). Pop. Biotechnology Center, the North Carolina Biosciences Organization (NCBIO) and the Biotechnology Industry Organization Biotechnology Industry Organization or BIO was founded 1993 in Washington, DC. James C. Greenwood is BIO's current President. External links
Held at the RTP's Sheraton Imperial Hotel and Convention Center, Biotech 2003: Fusing Science, Technology, and Business Leadership explained the state's role as a global player in life sciences and also offered insight into the future of biotechnology. The conference included eight interactive panels discussing biotechnology trends such as DNA DNA: see nucleic acid. DNA or deoxyribonucleic acid One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes. research, creative financing Creative Financing is a term used widely amongst real estate investors to refer to non-traditional means of real estate financing, or financing techniques not commonly used. and international partnerships. During lunch, Durham-based Trimeris, a biotech company spun out of research at Duke University, was recognized for its anti-HIV drug FUZEON, which recently received FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. approval. In addition, Biotech 2003 featured keynote remarks from industry and government leaders. Mary Tanner, senior managing director of the Investment Banking/Healthcare Group of Bear & Stearns Co., Inc, discussed biotech and pharmaceutical stock market trends. Steve Burrill, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. and founder of San Francisco-based Burrill & Company, highlighted investment trends guiding future activity in biotechnology. North Carolina Governor Mike Easley Michael Francis (Mike) Easley (born March 23, 1950) is the current governor of the U.S. state of North Carolina. He is a Democrat and North Carolina's second Catholic governor. , who commemorated the day's events by calling May 21 "Biotech Day," spoke of the industry's importance to North Carolina's economic future. Easley said he would work to ensure funding for biomanufacturing job training programs in the state. Helga Leftwich, a member of Hutchison & Mason PLLC PLLC Professional Limited Liability Company PLLC Polk Life and Learning Center (Bartow, FL) PLLC Partners of Limited Liability Corporation and co-chair of Biotech 2003, said the conference showcased past, present and future achievements of the state's biotech community. "Biotech 2003 celebrates the progress North Carolina has made, and will continue to make, in biotechnology. As seen by the crowd today, people's enthusiasm toward biotechnology continues," Leftwich said. "With the strong infrastructure including universities, community colleges, biotech investors, well-respected corporations, and entrepreneurs, North Carolina's potential is tremendous." Monica Doss, CED's president, said North Carolina's collaborative and innovation-based climate makes the state an attractive place for biotechnology. "The Triad's infrastructure is coming on very strong in terms of recent company investments and the N.C. Biotech Center's location of a new office," Doss said. "In addition, Asheville has some interesting options in terms of building its biotech economy. From the mountains to coast, North Carolina continues to improve upon its strong biotech environment." About CED: The Council for Entrepreneurial Development, located in Research Triangle Park, NC, is a private, non-profit organization A non-profit organization (abbreviated "NPO", also "non-profit" or "not-for-profit") is a legally constituted organization whose primary objective is to support or to actively engage in activities of public or private interest without any commercial or monetary profit purposes. formed in 1984 to stimulate the creation and growth of high-impact companies in the greater Research Triangle region. CED provides education, mentoring and capital formation resources to new and existing high-growth entrepreneurs through annual conferences, seminars, workshops and monthly programs on entrepreneurial management and finance. CED is the largest entrepreneurial support organization in the nation with more than 4,000 members representing 1,100 entrepreneurial companies, financiers and professional firms. www.cednc.org About the North Carolina Biotechnology Center: The North Carolina Biotechnology Center is a private, non-profit corporation funded primarily by the state's General Assembly. Its mission is to provide long-term economic and societal benefits to North Carolina by supporting biotechnology research, business and education statewide. www.ncbiotech.org About the North Carolina Biosciences Organization: NCBIO is a trade organization promoting the development of the biosciences industry in North Carolina. NCBIO provides cost-effective, organized legislative and advocacy efforts on behalf of the industry at the state and federal levels. About the Biotechnology Industry Organization: The Biotechnology represents more than 1,000 biotechnology companies Top 100 Biotechnology Companies The following is a list of the top 100 biotechnology companies ranked by revenue. The first nine companies qualify for the list of the top 50 pharmaceutical companies. , academic institutions, state biotechnology centers and related organizations in all 50 U.S. states and 33 other nations. BIO members are involved in the research and development of healthcare, agricultural, industrial and environmental biotechnology products. www.bio.org |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion